Stay updated on Nivolumab in AML Prevention Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.

Latest updates to the Nivolumab in AML Prevention Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a new page revision in the metadata.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing v3.6.0, signaling a small update to the page template or backend; no study details or public information were changed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now states 'No longer looking for participants', indicating the REMAIN trial is not currently enrolling. This reflects a shift in recruitment status for the AML maintenance study and affects potential participants' ability to join.SummaryDifference0.3%

- Check29 days agoChange DetectedA new Sample Collection section was added. The protocol was updated to Revision v3.5.5, replacing v3.5.4.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page's revision tag has been updated from v3.5.3 to v3.5.4, indicating a newer version of the site's underlying platform. This change represents a version upgrade rather than a modification to visible content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s footer revision identifier was updated from v3.5.2 to v3.5.3, reflecting a site/version maintenance update.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.